Related Experiment Video
Updated: May 11, 2026

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
Published on: January 30, 2017
Laboratory evaluation of a rapid diagnostic test for Neisseria meningitidis serogroup A
Aude Terrade1, Jean-Marc Collard, Farida Nato
1Institut Pasteur, Invasive Bacterial Infection Unit, National Reference Centre for Meningococci, and WHO Collaborating Centre for Meningococci, Paris, France.
Background:
Epidemics of meningococcal meningitis occur periodically in the African 'meningitis belt' and are mainly, but not only, due to serogroup A.
Methods:
We tested a dipstick as a rapid detection test (RDT) to detect serogroup A using 401 cerebrospinal fluid (CSF) samples.
Results:
The detection limits were 10(5) CFU/ml with sensitivity and specificity for detecting serogroup A in CSF samples of 88% and 99%, respectively.
Conclusions:
The new RDT can be used in field surveillance of meningococcal meningitis to help characterize meningitis cases particularly after introduction of the conjugate vaccine against serogroup A.
Insights
A new rapid detection test (RDT) effectively identifies serogroup A in cerebrospinal fluid samples, aiding surveillance for meningococcal meningitis outbreaks in Africa.
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- Recurrent epidemics of meningococcal meningitis occur in Africa's meningitis belt.
- Serogroup A is a primary, but not exclusive, cause of these outbreaks.
Purpose of the Study:
- To evaluate a novel rapid detection test (RDT) for Neisseria meningitidis serogroup A.
Main Methods:
- The RDT was tested using 401 cerebrospinal fluid (CSF) samples.
- Performance was assessed against established diagnostic criteria.
Main Results:
- The RDT demonstrated a detection limit of 10(5) CFU/ml.
- Sensitivity for serogroup A detection in CSF was 88%, with a specificity of 99%.
Conclusions:
- The developed RDT is suitable for field surveillance of meningococcal meningitis.
- This tool can assist in characterizing meningitis cases, especially post-introduction of the serogroup A conjugate vaccine.
Related Concept Videos
Viral Meningitis
Bacterial Meningitis I: Introduction
